History
Ground-breaking discoveries originating from Swedish research
BioArctic was founded in 2003 by Professor Lars Lannfelt and Dr. Pär Gellerfors to develop important breakthrough discoveries made by Professor Lannfelt regarding Alzheimer’s disease. These discoveries – the Swedish mutation and the Arctic mutation – have attracted much attention internationally and explain the central role of amyloid-beta in Alzheimer’s disease, which has led to the development of new treatment strategies. The company’s technology is now also used for other disorders of the central nervous system.
1992
2000
2001
2003
2004
2005
2006
2007
2008
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022